NCT02601898View on ClinicalTrials.gov

Vaginal Administration of ALA vs Progesterone for the Subchorionic Hematoma Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

November 30, 2015

Conditions
Subchorionic Hematoma in the First Trimester PregnancyMiscarriage
Interventions
DEVICE

Lipoic acid

Vaginal capsules (medical device) containing 10 mg of lipoic acid (1 per day)

DRUG

Progesterone

Vaginal capsules (drug) containing 200 mg of progesterone (2 per day)

Trial Locations (1)

Unknown

Azienda USL Ferrara, Ferrara

All Listed Sponsors
lead

Azienda USL Ferrara

OTHER_GOV

NCT02601898 - Vaginal Administration of ALA vs Progesterone for the Subchorionic Hematoma Treatment | Biotech Hunter | Biotech Hunter